ArticleCancer gene therapy2023

Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas.

Graziella R de Sousa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.